Gilead Sciences Announces First Quarter 2017 Financial Results

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/12/2026

1. MIRM
2. SPY
3. META
4. MSFT
5. PLTR
6. JNJ
7. LDOS
8. HUM
9. CSCO
10. KTOS

Go back to Gilead Sciences Announces First Quarter 2017 Financial Results

Gilead Sciences (GILD) PT Raised to $76 at BMO Capital Following 1Q

May 3, 2017 9:17 AM EDT

BMO Capital raised its price target on Gilead Sciences (NASDAQ: GILD) to $76.00 (from $75.00) while maintaining a Market Perform rating. GILD reported 1Q revenues of $6.5bn, below the Street's estimates of $6.62bn, as continued strength from HIV could not off-set further deterioration in HCV.

GILD... More

Gilead Sciences (GILD) Misses Q1 EPS by 5c; Reiterates Full Year 2017 Guidance

May 2, 2017 4:02 PM EDT

Gilead Sciences (NASDAQ: GILD) reported Q1 EPS of $2.23, $0.05 worse than the analyst estimate of $2.28. Revenue for the quarter came in at $6.505 billion versus the consensus estimate of $6.62 billion.

Reiterates Full Year 2017 Guidance

For earnings history and earnings-related data on Gilead Sciences (GILD) click here.

... More